Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial updating vaccine therapy for persistent or recurrent cervical cancer has been completed with results posted.
-
FDA approval · 2020-08-20FDA Approved: TOPOTECAN HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's supplemental application for Topotecan Hydrochloride, a generic chemotherapy drug, supporting its labeling …
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer [Phase 2]
Phase 2 clinical trial update investigating selective pelvic lymphadenectomy for cervical cancer.
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer [Phase 2]
Phase 2 trial evaluating nivolumab in patients with persistent, recurrent, or metastatic cervical cancer; results were posted in August 2020…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter [Phase 3]
Phase 3 trial studying dalteparin to prevent complications in cancer patients receiving chemotherapy via a catheter completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer [Phase 2, Phase 3]
A clinical trial update assessing bevacizumab's efficacy and safety in untreated locally advanced cervical cancer across Phase 2 and Phase 3…
-
CLINICAL_TRIALS trial_result · 2020-06-22Clinical Trial Update: A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab [Phase 1]
Phase 1 study evaluating MEDI4736 (durvalumab) in combination with tremelimumab has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213) [Phase 3]
Phase 3 study evaluating the immunogenicity, safety and tolerability of the quadrivalent HPV vaccine V501 in Chinese girls aged 9-19 and you…
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer. [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a Pd-1 antibody combined with concurrent chemoradiotherapy for local advanced cervical cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer [Phase 1, Phase 2]
Clinical trial updates on chemoradiotherapy followed by tegafur-based therapy in cervical cancer (Phase 1/Phase 2).
-
CLINICAL_TRIALS research · 2020-03-12Clinical Trial Update: Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women [NA]
A completed clinical trial evaluating collaborative care to reduce depression and increase cancer screening among low-income urban women.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer [Phase 2]
Phase 2 trial update evaluating dose optimization in 3D pulsed dose rate brachytherapy for locally advanced cervical cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial) [NA]
A completed IDEAL-GYN trial reported dose escalation for advanced and localized gynecologic cancer (cervical cancer).
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Honduras Liger Thermocoagulator Study [NA]
Clinical trial update for a study on a thermocoagulator in cervical lesions, completed with results posted in 2020.
-
FDA approval · 2020-03-05FDA Approved: CARBOPLATIN — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for carboplatin filed by Apotex Corp., authorizing changes to an approved generic product.
-
CLINICAL_TRIALS research · 2020-02-28Clinical Trial Update: Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. [Phase 4]
Phase 4 trial evaluating fluciclovine uptake in cervical, endometrial, and ovarian epithelial cancers.
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine [Phase 3]
Phase 3 study evaluating efficacy and immunogenicity of a recombinant HPV bivalent vaccine targeting types 16/18; trial completed.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study [EARLY_Phase 1]
A pilot study evaluating a rapid recovery program in gynecologic oncology surgery has completed early-phase research with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma. [Phase 2]
Phase 2 clinical trial evaluating Oncoxin-Viusid in cervical cancer and endometrial adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) [Phase 3]
Phase 3 trial update on immunogenicity and tolerability of a broad-spectrum HPV vaccine (V503-004) with completed status and results posted …
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer [Phase 2]
Phase 2 clinical trial evaluating concurrent chemoradiotherapy (CCRT) combined with Endostar for locally advanced cervical cancer.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial of CAR T cell therapy targeting mesothelin in metastatic cancer shows terminated status with posted results.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer [Phase 2]
Phase 2 trial investigating SABR as definitive treatment for locally advanced cervical cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer [Phase 2]
Phase 2 trial updating combination therapy of a PD-1 monoclonal antibody with an HPV vaccine for cervical cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix [Phase 3]
Phase 3 trial comparing neoadjuvant chemotherapy followed by surgery versus concurrent chemoradiation for carcinoma of the cervix.